Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 213-485-0 | CAS number: 957-68-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu./o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- October 18, 1994 to November 08, 1994
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study (OECD 406) with acceptable restrictions.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- 3-acetoxymethylen-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- EC Number:
- 213-485-0
- EC Name:
- 3-acetoxymethylen-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- Cas Number:
- 957-68-6
- Molecular formula:
- C10H12N2O5S
- IUPAC Name:
- (6R,7R)-3-[(acetyloxy)methyl]-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Name of test material (as cited in study report): 7-ACA
- Physical state: white powder
- Analytical purity: 95%-102% (HPLC)
- Batch No.: 3701586
- Expiration date of the batch: stable under conditions of storage
- Storage condition of test material: in a refrigerator in the dark
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- Animals:
Hartley guinea pigs, Crl:(HA)BR.
Supplier: Charles River Wiga GmbH, D-32791 Sulzfeld.
Female healthy young adult and non pregnant animals.
Number in the preliminary study: 3
Number in the main study: 30
Body weight at receipt: ca. 300 g
Age at first application: ca. 6 weeks
Environmental conditions:
Hygiene: improved hygienic conditions.
Room number: EH1-21
Room temperature: average of ca. 22.5 °C.
Relative humidity: average of 45 %.
Control of room temp, and rel. humidity: continuous control and recording
Air exchange: ca. 12/h
Light: only artificial light from 6.00 a.m. to 6.00 p.m
Cages: Makrolon cages type m (23 cm x 39 cm x 15 cm) with wire mesh lids, single caging
Feed: Altromin Standard Diet No. 3022, ad libitum, offered in stainless steel containers. Analysis of the feed for ingredients and contaminants are performed randomly by Altromin GmbH, D-32791 Lage.
Bedding material: wood chips (aspen) from FINN TAPVEIKY, SF-73600 Kaavi. Reduction of microorganisms by autoclaving.
Water: tap water, acidified with HC1 to pH = 3, offered in Makrolon bottles with stainless steel canules, ad libitum.
Identification of the animals: numbers tattooed in the pinna of the right ear.
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- physiological saline
- Remarks:
- and white petrolatum
- Concentration / amount:
- The concentrations of the test substance used for each induction exposure should be well-tolerated systemically and should be the highest to cause mild-to-moderate skin irritation. The concentration used for the challenge exposure should be the highest non irritant one.
To obtain the appropriate concentrations of the test substance for the main study, a preliminary test was carried out with 3 female guinea pigs. 4 different concentrations of the test substance were administered epicutaneously in the lumbar region and 4 different concentrations were applied intradermally in the interscapular region. Mode of application was the same as in the main study. Duration of the epicutaneous exposure was 24 hours.
Intradermal injection:
Test substance concentrations were 5 %, 1 %, 0.1 % and 0.01 % in physiological saline. At the concentration of 5 % very slight to severe erythema and/or oedema to the skin were noted in all animals 24 and/or 48 hours after the application. No skin reaction occurred at the other concentrations. Therefore a concentration of 5 % in physiological saline was used for the intradermal induction in the main study.
Epicutaneous exposures:
Test substance concentrations were 40 %, 10 %, 2.5 % and 0.5 % in white petrolatum. No adverse skin reactions were observed at any of these concentrations. Therefore it was decided to use 40 % for the epicutaneous induction and for the challenge exposure. 40 % is also the highest technically feasible concentration for an applicable formulation in white petrolatum. According to B. Magnusson and A.M. Kligman, it was also decided to pretreat the animals with n-dodecylsulfate, sodium salt, before the epicutaneous induction exposure.
Challengeopen allclose all
- Route:
- epicutaneous, open
- Vehicle:
- physiological saline
- Remarks:
- and white petrolatum
- Concentration / amount:
- The concentrations of the test substance used for each induction exposure should be well-tolerated systemically and should be the highest to cause mild-to-moderate skin irritation. The concentration used for the challenge exposure should be the highest non irritant one.
To obtain the appropriate concentrations of the test substance for the main study, a preliminary test was carried out with 3 female guinea pigs. 4 different concentrations of the test substance were administered epicutaneously in the lumbar region and 4 different concentrations were applied intradermally in the interscapular region. Mode of application was the same as in the main study. Duration of the epicutaneous exposure was 24 hours.
Intradermal injection:
Test substance concentrations were 5 %, 1 %, 0.1 % and 0.01 % in physiological saline. At the concentration of 5 % very slight to severe erythema and/or oedema to the skin were noted in all animals 24 and/or 48 hours after the application. No skin reaction occurred at the other concentrations. Therefore a concentration of 5 % in physiological saline was used for the intradermal induction in the main study.
Epicutaneous exposures:
Test substance concentrations were 40 %, 10 %, 2.5 % and 0.5 % in white petrolatum. No adverse skin reactions were observed at any of these concentrations. Therefore it was decided to use 40 % for the epicutaneous induction and for the challenge exposure. 40 % is also the highest technically feasible concentration for an applicable formulation in white petrolatum. According to B. Magnusson and A.M. Kligman, it was also decided to pretreat the animals with n-dodecylsulfate, sodium salt, before the epicutaneous induction exposure.
- No. of animals per dose:
- group: K7 negative control, animal Nos.: 231 - 240, sex: f, exposure: induction exposure (intradermal with physiological saline, epicutaneous with white petrolatum), challenge exposure (left flank with 40 % test substance in white petrolatum, right flank with white petrolatum)
group: M test substance, animal Nos.: 241 - 260, sex: f, exposure: induction exposure (intradermal with 5% test substance in physiological saline, epicutaneous with 40% test substance in white petrolatum), challenge exposure (left flank with 40 % test substance in white petrolatum, right flank with white petrolatum) - Details on study design:
- First induction exposure: intradermal injections of the test substance, of FCA (to enhance a possible sensitisation) and of the test substance diluted with FCA. Application site was an area of approx. 2 cm x 4 cm in the interscapular region.
Second induction exposure: epicutaneous application of the test substance to the sites of the intradermal injections.
Positive skin reactions of the test substance treated sites after the challenge exposure indicate a sensitising effect of the test substance, if the scores are higher than those of the vehicle treated sites and if the rate of those - positively reacting - animals is higher than the corresponding percentage of animals in the negative control group.
Time Schedule:
Day 0 removal of hair, recording of body weight, intradermal induction exposure.
Day 1 examination of injection sites.
Day 6 removal of hair, treatment with n-dodecylsulfate, sodium salt.
Day 7 epicutaneous induction exposure.
Day 9 end of epicutaneous induction exposure.
Day 10 skin examination.
Day 21 removal of hair, epicutaneous challenge exposure.
Day 22 end of epicutaneous challenge period.
Day 23 approximately 21 hours after removing the patch cleaning of the challenge area, approximately 3 hours later skin examination.
Day 24 skin examination, recording of body weight, sacrifice of animals, fixation of the test substance treated- and vehicle sites, end of test
Clipping of hair:
On the respective days (see also 2.9.) the hair of the animals was clipped closely on the appropriate application sites with an Aesculap GH 204 electric hair clipper with a 1 mm and then with a 0.1 mm cutterhead.
Preparation and administration of the test substance:
All formulations of the test substance were prepared immediately before administration.
Intradermal induction exposure:
Stock solution of the test substance: 1000 mg of the test substance were suspended in 6.0 ml physiological saline. 4.0 ml of 1 m NaOH solution were added drop by drop under stirring to obtain a solution. The final concentration of the test substance was 10 %. This solution was further diluted (see below).
Cranial row: both groups: Freund's complete adjuvant (FCA), 1+1 (v/v) blended with physiological saline.
Middle row: control group: physiological saline
test substance group: test substance, final concentration: 5 % (w/v) in physiological saline.
Caudal row: control group: FCA, 1+1 (v/v) blended with physiological saline
test substance group: test substance, 5 % (w/v) final concentration in: physiological saline, 1+1 (v/v) blended with FCA.
A volume of 0.1 ml was applied for each injection site.
Epicutaneous induction exposure:
The highest technically feasible test substance concentration of 40 % in white petrolatum did not cause markable skin irritations in the preliminary test in the animals. According to B. Magnusson and A.M. Kligman, all animals of both groups were therefore pretreated with a formulation of n-dodecylsulfate, sodium salt (E. Merck, D-64274 Darmstadt, Art. No. 13760), 10 % (w/w) in white petrolatum, one day before the epicutaneous induction exposure. About 0.5 g per animal was gently applied with a plastic spatula onto the appropriate area to give a slight local hyperaemia. The area was left uncovered.
For the induction exposure, filter papers, about 2 cm x 4 cm, wer covered with the test substance, 40 % in white petrolatum (test substance group) and with white petrolatum (control group), resp. They were applied to the area of the intradermal injections and were fixed occlusively with a strip of non-irritating tape ("Blenderm®" surgical tape, hypoallergenic, 3M, made in USA, Medical Products Division, St. Paul, MN 551444). The area of administration was then covered occlusively with aluminium foil and finally fixed with "Fixomull® stretch" (self adhesive non woven fabric, hypoallergenic, made by Beiersdorf AG, D-20245 Hamburg). Exposure time was 48 hours. About 0.7 g of test substance formulation and of white petrolatum, resp., were applied to each animal. - Challenge controls:
- Challenge exposure: epicutaneous application of the test substance to the left flanks and application of the vehicle to the right flanks of all animals.
2.11.3. Challenge exposure
Filter papers, about 2 cm x 2 cm, covered with the test substance, 25 % in white petrolatum, were applied to the left flanks of all animals of both groups. Filter papers of the same size, covered with white petrolatum, were applied to the right flanks of all animals. Mode of fixation was the same as for the epicutaneous induction exposure. About 0.7 g of test substance formulation and about 0.6 g of white petrolatum were applied to each animal. - Positive control substance(s):
- yes
- Remarks:
- 1,4-phenylenediamine
Results and discussion
- Positive control results:
- Results of the last check, performed in September/October 1994 (guinea pig maximisation test,
same methods as in the actual study):
Positive control substance: 1,4-phenylenediamine.
Concentrations:
0.5 % in physiological saline for intradermal induction exposure 10 % in white petrolatum for epicutaneous induction exposure 5 % in white petrolatum for epicutaneous challenge exposure.
Number of animals: 5 female guinea pigs for 1,4-phenylenediamine and 5 female guinea pigs for a control group (same strain of animals, supplier, animal maintenance, feed etc. as in the actual study)
Results after challenge exposure: The control areas of all animals were normal. There were no positive skin reactions at the 1,4-phenylenediamine treated sites of the negative control group. In the positive control group 5/5 animals, i.e. 100 %, had positive reactions on the 1,4-phenylenediamine treated sites 24 and 48 hours after the end of the challenge exposure and were regarded as sensitised.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No animal had a "positive skin reaction".
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: No animal had a "positive skin reaction"..
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No animal had a "positive skin reaction".
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: No animal had a "positive skin reaction"..
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Clinical observations:
- 20/20 animals were regarded as sensitised
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. No with. + reactions: 20.0. Total no. in groups: 20.0. Clinical observations: 20/20 animals were regarded as sensitised.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Clinical observations:
- 20/20 animals were regarded as sensitised
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. No with. + reactions: 20.0. Total no. in groups: 20.0. Clinical observations: 20/20 animals were regarded as sensitised.
Any other information on results incl. tables
Mortality: All animals survived till the end of the study.
Body weight: There were no significant differences in mean body weights between the test substance group and the control group on Days 0 and 24.
General observations: Immediately after the beginning of all epicutaneous exposures (induction, challenge) the motor activities of all animals were increased. This is due to the dressings which restrict the freedom of movement. Soon afterwards the behaviour was regular again. Except of the observations described above no abnormal behaviour or clinical signs were detected during the experiment in the animals.
Skin reactions:
Skin reactions after intradermal induction exposure: Cranial and caudal injection sites: Local irritations were observed in all animals beginning on the day after the injections. The irritations started with local erythema, which became more severe and led to ulcerations. Lesions did not heal until the end of the study. This local alterations are known effects of Freund's adjuvant.
Middle injection sites: No irritative reactions were observed 24 hours after induction exposure in the negative control group. Very slight to severe erythema and/or oedema were noted in 15/20 animals of the test substance group.
Skin reactions after epicutaneous induction exposure: The reactions caused by the adjuvant obscured the reading of reactions following the epicutaneous induction exposure in this area. All animals had severe erythema and oedema in the interscapular region (score "3"), which were attributed to the effects of the adjuvant.
Skin reactions after challenge exposure: These are the reactions of major interest for the grading of an allergenic potency of the test substance.
Negative control group:
Vehicle site: no positive skin reaction in any animal at any reading time.
Test substance site: no positive skin reaction in any animal at any reading time. No animal had a "positive skin reaction".
Test substance group:
Vehicle site: no positive skin reaction in any animal at any reading time.
Test substance site: very slight to severe erythema and/or oedema in all animals 24 and/or 48 hours after the end of the challenge exposure, eschars in one animal.
20/20 animals were regarded as sensitised.Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- 20/20 animals of the test substance group, i.e. 100 % of the animals, were regarded as sensitised. As no animal of the vehicle control group had a positive skin reaction, this was also the net rate of sensitised animals in the test substance group.
According to the EC-Guideline 93/21 (April 27, 1993), the test substance "7-ACA" should be labelled with "R43 May cause sensitisation by skin contact". - Executive summary:
The "maximisation test" ofb.Magmisson and A.m.Kligman was performed to reveal a possible sensitising potential of "7-ACA". 20 female guinea pigs were used as a test substance group and another 10 females were used as a negative control group. There were two induction exposures (intradermally and epicutaneously) and one epicutaneous challenge exposure. Test substance concentrations were
• 5 % in physiological saline for the intradermal induction
• 40 % in white petrolatum for the epicutaneous induction and
• 40 % in white petrolatum for the challenge exposure.
Investigations performed were in conformance with the OECD-guideline 406, "Skin Sensitisation", July 7,1992. Application of Freund's complete adjuvant was included in the intradermal exposure of both groups to enhance a possible sensitisation.
Results General:
All animals survived till the end of the study. Intradermal injections of Freund's adjuvant caused severe local reactions in all animals, a known effect of the adjuvant. Sensitisation excluded, no other adverse effects were noted.
Skin reactions after the challenge exposure:
In the negative control group, the control sites and also the test substance treated sites of all animals were normal at any observation time.
In the test substance group, the control sites of all animals were also normal. At the test substance treated sites, positive skin reactions were noted in 20/20 animals. These animals, i.e. 100 % of the test substance group animals, were regarded as sensitised.
According to the EC-Guideline 93/21 (April 27, 1993), the test substance "7-ACA"should be labelledwith "R43 May cause sensitisation by skin contact".
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)